Diagnostic Trials

Madhu Mazumdar (), Xiaobo Zhong () and Bart Ferket ()
Additional contact information
Madhu Mazumdar: Mount Sinai Health System, Director of Institute for Healthcare Delivery Science
Xiaobo Zhong: Ichan School of Medicine at Mount Sinai
Bart Ferket: Ichan School of Medicine at Mount Sinai

Chapter 63 in Principles and Practice of Clinical Trials, 2022, pp 1171-1197 from Springer

Abstract: Abstract The term diagnostic trial is generally used in two different ways. A diagnostic trial type I describes studies that evaluate accuracy of diagnostic tests in detecting disease or its severity. Primary endpoints for these studies are generally test accuracy outcomes measured in terms of sensitivity, specificity, positive predictive value, negative predictive value, and area under the receiver operating characteristics curves. Although establishing an accurate diagnosis or excluding disease is a critical first step to manage a health problem, medical decision-makers generally rely on a larger evidence base of empirical data that includes how tests impact patient health outcomes, such as morbidity, mortality, functional status, and quality of life. Therefore, the diagnostic trial type II evaluates the value of test results to guide or determine treatment decisions within a broader management strategy. Typically, differences in diagnostic accuracy result in differences in delivery of treatment, and ultimately affect disease prognosis and patient outcomes. As such, in the diagnostic trial type II, the downstream consequences of tests followed by treatment decisions are evaluated together in a joint construct. These diagnostic randomized clinical trials or test-treatment trials are considered the gold standard of proof for the clinical effectiveness or clinical utility of diagnostic tests. In this chapter, we define the variety of accuracy measures used for assessing diagnostic tests, summarize guidance on sample size calculation, and bring attention to the importance of more accurate reporting of study results.

Keywords: Diagnostic trial type I; Diagnostic trial type II; Test-treatment trial; Sensitivity; Specificity; Positive predictive value; Negative predictive value; Area under the receiver operating characteristics curves (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-319-52636-2_281

Ordering information: This item can be ordered from
http://www.springer.com/9783319526362

DOI: 10.1007/978-3-319-52636-2_281

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().